New ASMI directors
January 29, 2016
THE Australian Self Medication
Industry (ASMI) yesterday
announced the appointment of
former Reckitt Benckiser regional
director Australia and NZ, Lindsay
Forrest, as its new chairperson.
ASMI ceo Deon Schoombie
congratulated and welcomed
Forrest to the role, saying, “Lindsay
has a long and distinguished
history in the consumer healthcare
products industry and is a
recognised industry leader.
“Lindsay’s extensive experience
in sales, marketing, general
management, regional multi country
management and global
strategy gives him unique insights
into the exciting opportunities
and challenging issues facing the
industry.”
Schoombie also congratulated
and welcomed Paul Rose (Pfizer) as
Vice Chairperson and James Jones
(Takeda) as Secretary.
Announcing the senior executive
appointments, Schoombie also
warmly thanked outgoing ASMI
president Mark Sargent for
“his leadership and immense
contribution to ASMI and the
industry,” hailing his leadership of
ASMI’s advocacy on critical industry
issues”.
“This is an exciting time for the
industry as we drive regulatory
reform to enhance consumer
access to medicines and promote
the integration of self care into
national health policy,” Schoombie
concluded.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 16
